I. Led by International Authorities, Experts Gather to Share Insights
Hosted by Beijing Anding Hospital, Capital Medical University, and organized by the Capital Huizhi Institute for Medical Technology Transfer, this premier international forum is the first in the Asia-Pacific region to fully align with the U.S. CNS Summit. Dr. Amir Kalali, Chairman of the U.S. CNS Summit, has been invited to serve as Honorary Chair and Chief Curator, leading a delegation of top-tier international experts to Beijing. The event brings together distinguished Chinese scholars, including Academician Jiang Tao, alongside prominent global industry leaders such as Dr. Owen Muir, who led the development of the world’s first FDA-approved non-invasive neuromodulation device for at-home depression treatment, and Dr. Craig Lipset, Co-Founder and Co-Chair of the Decentralized Trials & Research Alliance (DTRA). By convening leading figures from academia, industry, investment, and incubation sectors in China and the United States, the forum aims to facilitate technology transfer through high-level, forward-looking dialogues on industrial innovation.
II. Four Vertical Sub-Forums for Comprehensive Industry Resource Matchmaking
Focusing on four core sectors: innovative drug R&D, digital health, neuromodulation technology, and precision medicine technology, 24 frontierCorporate Roadshow+ Dedicated exhibition zones work in synergy to build a closed loop of “roadshow–exhibition–exchange–matchmaking,” connecting the entire chain from “research–clinical practice–translation–industry–globalization.”
III. Six Major 1-on-1 Precision Consultations: Comprehensively Resolving Conversion Pain Points Across the Entire Chain
The forum features six specialized consulting zones focused on precise themes: innovation incubation, CRO collaboration, clinical center operational optimization, global market access, life sciences investment, and medical device R&D and registration. More than 14 senior industry experts will be available on-site to provide one-stop solutions for core challenges such as project incubation, clinical collaborations, overseas regulatory registration, financing matchmaking, and device submissions, thereby facilitating the efficient commercialization of innovative achievements.
IV. A High-End, Pragmatic Summit Empowering the Globalization of the Industry
With an expected attendance of over 450 professionals, the event features a hybrid main forum (both online and offline) and closed-door sub-forums for precise matchmaking, aiming to establish a high-caliber, resource-concentrated, and pragmatically oriented international benchmark platform for CNS medical innovation in China.